IRS1 and endothelial dysfunction: In individuals with insulin resistance insulin signaling is impaired at the level of Insulin Receptor Substrate-1 (IRS-1), leading to decreased glucose transport/phosphorylation/metabolism and impaired nitric oxide synthase activation/endothelial dysfunction [5].